The DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index, and 1 are not checked yet.
Strategies used by people who inject drugs to avoid stigma in healthcare settings
Open accessAbstract
Background People who inject drugs (PWID) have limited engagement in healthcare services and report frequent experiences of stigma and mistreatment when accessing services. This paper explores the impact of stigma against injection drug use on healthcare utilization among PWID in the U.S. Northeast.Methods We recruited PWID through community-based organizations (CBOs; e.g., syringe service programs). Participants completed brief surveys and semi-structured interviews lasting approximately 45 min exploring HIV risk behaviors and prevention needs. Thematic analysis examined the emergent topic of stigma experiences in relation to healthcare utilization.Results Among 33 PWID (55% male; age range 24-62 years; 67% White; 24% Latino), most used heroin (94%) and injected at least daily (60%). Experiences of dehumanization in healthcare settings were common, with many participants perceiving that they had been treated unfairly or discriminated against due to their injection drug use. As participants anticipated this type of stigma from healthcare providers, they developed strategies to avoid it, including delaying presenting for healthcare, not disclosing drug use, downplaying pain, and seeking care elsewhere. In contrast to large institutional healthcare settings, participants described non-stigmatizing environments within CBOs, where they experienced greater acceptance, mutual respect, and stronger connections with staff.Conclusions Stigma against injection drug use carries important implications for PWID health. Increased provider training on addiction as a medical disorder could improve PWID healthcare experiences, and integrating health services into organizations frequented by PWID could increase utilization of health services by this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Building rapport and trust through low-threshold, non-stigmatizing services in community-based organizations, rather than in large institutional clinics, helps mitigate the anticipated discrimination that often deters these patients from seeking care [46].”
From Psychosocial Interventions for Improving Treatment Adherence in Tuberculosis Patients: A Scoping Review of Evidence-Based Approaches. (2026) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stigma: Notes on the Management of Spoiled Identity
(1969) · Postgraduate Medical Journal · doi:10.1136/pgmj.45.527.642 · Cited by 14,255 · cited 1×
“Stigma, defined by Goffman as a “deeply discrediting attribute,” is well researched among the larger population of people who use illicit drugs (Goffman, 1963; Kulesza et al., 2013).”
Lippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,095
Stigma as a fundamental cause of population health inequalities
Hatzenbuehler, M. L., Phelan, J. C., & Link, B. G. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.301069 · Cited by 2,674 · cited 1×
“Internalized stigma carries harmful effects on health and wellbeing (Ahern et al., 2007; Cama et al., 2016; Hatzenbuehler et al., 2013; Kamaradova et al., 2016; Luoma et al., 2007; Rivera et al., 2014; Skeer et al., 2018; von Hippel et al., 2018).”
Backgroundvan Boekel, L. C., Brouwers, E. P. M., van Weeghel, J., & Garretsen, H. F. L. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.02.018 · Cited by 1,810
DeCuir-Gunby, J. T., Marshall, P. L., & McCulloch, A. W. (2011) · Field Methods · doi:10.1177/1525822x10388468 · Cited by 1,456 · cited 1×
“We reviewed transcripts for quality and to identify emergent themes (DeCuir-Gunby et al., 2011).”
From Conceptualizing to Measuring HIV Stigma: A Review of HIV Stigma Mechanism Measures
Earnshaw, V. A., & Chaudoir, S. R. (2009) · AIDS and Behavior · doi:10.1007/s10461-009-9593-3 · Cited by 1,222 · cited 1×
“, “external reactions to stigma”) as they emerged (Earnshaw and Chaudoir, 2009).”
BackgroundSelf-stigma and the “why try” effect: impact on life goals and evidence-based practices
CORRIGAN, P. W., LARSON, J. E., & RÜSCH, N. (2009) · World Psychiatry · doi:10.1002/j.2051-5545.2009.tb00218.x · Cited by 1,074 · cited 3×
“Although little research has focused on building resilience among PWID, some group therapy interventions have demonstrated modest efficacy in building resilience among people living with mental illness and HIV (Corrigan et al., 2009; Mittal et al., 2012; Rao et al., 2018).”
BackgroundFurther evaluation of the Dutch supervision system for suicides of mental health care users
(2013) · EUR Research Repository (Erasmus University Rotterdam) · doi:10.1176/appi · Cited by 1,030
Livingston, J. D., Milne, T., Fang, M. L., & Amari, E. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03601.x · Cited by 927 · cited 1×
“interventions could help increase cultural competency and decrease stigma towards PWID at multiple levels within health organizations, such models require further research and evaluation (Brener et al., 2017; Livingston et al., 2012).”
BackgroundStigma, discrimination and the health of illicit drug users
Ahern, J., Stuber, J., & Galea, S. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.10.014 · Cited by 860 · cited 2×
“Internalized stigma carries harmful effects on health and wellbeing (Ahern et al., 2007; Cama et al., 2016; Hatzenbuehler et al., 2013; Kamaradova et al., 2016; Luoma et al., 2007; Rivera et al., 2014; Skeer et al., 2018; von Hippel et al., 2018).”
Background
Cited by
Sorted by citations
Items 501–525 of 525
Truncali, A., Craig, W. Y., & Silvia, K. (2026) · Substance Use & Addiction Journal · doi:10.1177/29767342261436911
Ponticiello, M. N., Bromberg, D. J., Azbel, L., Cugut, S., Doltu, S., & Altice, F. L. (2026) · PLOS Global Public Health · doi:10.1371/journal.pgph.0006317
“PWID in community settings rarely utilize conventional primary care and specialty services [36], in part due to high levels of stigma in such settings [37–39].”
The Groin and People Who Inject Drugs—Management and Pitfalls
Jackman, J., Guthrie, G. J. K., & Suttie, S. A. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm54135
Wakeman, S., Bachireddy, C., Campbell, A., Danovitch, I., Englander, H., Fuller, D., Herring, A., McCollough, M., Lindsay, D. L., Norrington, J., et al. (2026) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001729
Lyman, K., Choi, J., Jutras‐Aswad, D., Foll, B. L., Klaire, S. S., & Socias, M. E. (2026) · Drug and Alcohol Review · doi:10.1111/dar.70190
“Despite the higher prevalence of chronic pain among PWUD, they face multiple barriers in accessing treatment and appropriate pain management [3], with the lack of appropriate care described as a major barrier, as well as a contributor to substance use [4].”
Troberg, K., & Isendahl, P. (2026) · Harm Reduction Journal · doi:10.1186/s12954-026-01487-x
“The responsibility that follows improved opportunities to save lives with naloxone is complex as it mainly relies on members of society with a longstanding history of stigmatization from the same healthcare system now depends on their commitment [22–25].”
Chhun, N., Kamusiime, B., Nalumansi, A., Twesige, C. C., Nalukwago, G. K., Kasiita, V., Mudiope, P., Kansiime, R., Muwonge, T. R., Kyambadde, P., et al. (2026) · Addiction Science & Clinical Practice · doi:10.1186/s13722-026-00693-z
“Community perceptions and attitudes about addiction impact patterns of healthcare utilization [56, 57].”
Daly, S., & Stokes, G. (2026) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2026.105416
Elkamel, B., Meaders, S., Murphy, M. E., Chueng, T. A., Tookes, H., & Scheidell, J. D. (2026) · AJPM Focus · doi:10.1016/j.focus.2026.100536
Stokvis, C., Viste, D., Lemma, B., Su, L., Rioux, W., Ghosh, S. M., & VandenBerg, S. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-111225
“Stigma surrounding substance use (including metham-phetamines) is pervasive within healthcare settings, 21 and continues to be a central theme within our research.”
Forman, E., Eger, W. H., Akiba, C. F., Patel, S. V., Huffaker, S. L., Smith, J., Lambdin, B. H., Roth, A. M., & Bazzi, A. R. (2026) · Implementation Science Communications · doi:10.1186/s43058-026-01051-5
“However, this population often encounters stigma, discrimination, and other structural barriers that limit access to traditional healthcare settings, including primary care [5–7], and contribute to delayed treatment and reduced uptake of evidence-based preventative services [8].”
Swisher, E. M., Davis, M., Rubin-Saika, M., Manhardt, E., Oshima, E., Urban, R. R., Cherne, S., Lin, J. W., Winer, R. L., Huang, E. C., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.25993
Sociostructural correlates of clinical risk among Australian anabolic-androgenic steroid consumers
Bonenti, B., Kerswell, N. L., Shuttleworth, G., Ganson, K. T., Ferris, J., Nagata, J. M., & Piatkowski, T. M. (2026) · Addiction Research & Theory · doi:10.1080/16066359.2026.2707483
Cama, E. J., Martin, K., Brener, L., Pony, M., Treloar, C., Desgraves, G., & Broady, T. (2026) · Health Psychology and Behavioral Medicine · doi:10.1080/21642850.2026.2719269
“Participants were also asked four items measuring reduced access to health care due to stigma in the past 12 months, adapted from Biancarelli et al. (2019).”
Kearns, K., Galeano, R., & Alexander, L. (2026) · Journal of Clinical Nursing · doi:10.1111/jocn.70527
Broady, T. R., Ritchie, J., Foster, R., McNulty, A. M., Brener, L., & Treloar, C. (2026) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-026-03167-9
Kielhold, K., Shannon, K., Strong, D., Bazzi, A. R., Zhou, H., Campbell, C. K., Krüsi, A., Pitpitan, E. V., & Goldenberg, S. M. (2026) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2026.105479
Opheim, E., Malme, K. B., Dalgård, O., Rykkvin, R., Backe, Ø., Foshaug, T., Wüsthoff, L. E. C., & Midgard, H. (2026) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2026.105502
“You Do What You Have To Do”: Risk Environments in Xylazine Wound Care
Studnicki, O., Shang, M., Hull, I., Schultz, K., Halpern, D. V., Bell, A., Liebschutz, J. M., & Jawa, R. (2026) · Substance Use & Addiction Journal · doi:10.1177/29767342261489216
Cama, E. J., Horwitz, R., Yu, S., Wu, K. O. E., Broady, T., Treloar, C., & Brener, L. (2026) · Psychology Health & Medicine · doi:10.1080/13548506.2026.2746786
Shaw, L. C., Park, C. J., Pratty, C., Allen, B., Macmadu, A., Cerdá, M., & Marshall, B. D. L. (2026) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2026.105527
Recommendations to Enhance Engagement in Perinatal Research With People Who Inject Drugs
Marshall, A. D., Burton-McKeich, G. K., Taylor, N. J., Overton, K., Shand, A., Havard, A., & Russell, D. M. (2026) · Drug and Alcohol Review · doi:10.1111/dar.70283
Roos, M., Thoresen, L., Jansen, T., & Bondevik, H. (2026) · Contemporary Drug Problems · doi:10.1177/00914509261498943
Hegde, D., Thomas, R., Anu, K. N., & Johnson-Pradeep, R. (2026) · Journal of Addictive Diseases · doi:10.1080/10550887.2026.2747768
Metadata
- Authors
- Biancarelli, D. L., Biello, K. B., Childs, E., Drainoni, M., Salhaney, P., Edeza, A., Mimiaga, M. J., Saitz, R., & Bazzi, A. R.
- Affiliations
- Boston University (US)
- Brown University (US)
- Corresponding author
- Bazzi, Angela R.
- ORCID
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 198
- Pages
- 80-86
- ISSN
- 0376-8716 (ISSN-L)
- PMC
- PMC6521691
- OpenAlex
- W2921016611
- Cited by
- 524
- References
- 79
- Citations by year
- 2026: 51 · 2025: 92 · 2024: 109 · 2023: 79 · 2022: 73 · 2021: 69 · 2020: 42 · 2019: 8
- FWCI
- 36.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Drug and Alcohol Dependence (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Providence/Boston Center for AIDS Research (P30AI042853)
- NIH/NIDA (K01DA043412)
- BU Peter Paul Career Development Professorship
- Topics
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- people who inject drugs, stigma, health care utilization, dehumanization, community organizations, syringe services programs, HIV risk behavior, provider training, integrated care
- MeSH terms
- Adult, Female, Health Personnel, Humans, Male, Middle Aged, New England, Patient Acceptance of Health Care, HIV Infections, Substance Abuse, Intravenous, Drug Users, Young Adult, Social Stigma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
